BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 11733227)

  • 21. Mice transgenic for a vasopressin-SV40 hybrid oncogene develop tumors of the endocrine pancreas and the anterior pituitary. A possible model for human multiple endocrine neoplasia type 1.
    Murphy D; Bishop A; Rindi G; Murphy MN; Stamp GW; Hanson J; Polak JM; Hogan B
    Am J Pathol; 1987 Dec; 129(3):552-66. PubMed ID: 2827490
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Myc-dependent angiogenic switch in tumors is mediated by interleukin 1beta.
    Shchors K; Shchors E; Rostker F; Lawlor ER; Brown-Swigart L; Evan GI
    Genes Dev; 2006 Sep; 20(18):2527-38. PubMed ID: 16980582
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multiple endocrine neoplasia type 1 gene maps to chromosome 11 and is lost in insulinoma.
    Larsson C; Skogseid B; Oberg K; Nakamura Y; Nordenskjöld M
    Nature; 1988 Mar; 332(6159):85-7. PubMed ID: 2894610
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lack of MEN1 gene mutations in 27 sporadic insulinomas.
    Cupisti K; Höppner W; Dotzenrath C; Simon D; Berndt I; Röher HD; Goretzki PE
    Eur J Clin Invest; 2000 Apr; 30(4):325-9. PubMed ID: 10759881
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tumor cells utilize multiple pathways to down-modulate apoptosis. Lessons from a mouse model of islet cell carcinogenesis.
    Hager JH; Hanahan D
    Ann N Y Acad Sci; 1999; 887():150-63. PubMed ID: 10668471
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Alpha cell-specific Men1 ablation triggers the transdifferentiation of glucagon-expressing cells and insulinoma development.
    Lu J; Herrera PL; Carreira C; Bonnavion R; Seigne C; Calender A; Bertolino P; Zhang CX
    Gastroenterology; 2010 May; 138(5):1954-65. PubMed ID: 20138042
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vivo proliferation of differentiated pancreatic islet beta cells in transgenic mice expressing mutated cyclin-dependent kinase 4.
    Hino S; Yamaoka T; Yamashita Y; Yamada T; Hata J; Itakura M
    Diabetologia; 2004 Oct; 47(10):1819-30. PubMed ID: 15480536
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Alterations in gene expression in MEN1-associated insulinoma development.
    Serewko-Auret MM; Mould AW; Loffler KA; Duncan R; Kay GF; Hayward NK
    Pancreas; 2010 Nov; 39(8):1140-6. PubMed ID: 20531244
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mutation of the MENIN gene in sporadic pancreatic endocrine tumors.
    Wang EH; Ebrahimi SA; Wu AY; Kashefi C; Passaro E; Sawicki MP
    Cancer Res; 1998 Oct; 58(19):4417-20. PubMed ID: 9766672
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pancreatic tumor pathogenesis reflects the causative genetic lesion.
    Sandgren EP; Quaife CJ; Paulovich AG; Palmiter RD; Brinster RL
    Proc Natl Acad Sci U S A; 1991 Jan; 88(1):93-7. PubMed ID: 1986386
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mutational analysis of p27 (CDKN1B) and p18 (CDKN2C) in sporadic pancreatic endocrine tumors argues against tumor-suppressor function.
    Lindberg D; Akerström G; Westin G
    Neoplasia; 2007 Jul; 9(7):533-5. PubMed ID: 17710155
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Conditional transformation of mouse liver epithelial cells. An in vitro model for analysis of genetic events in hepatocarcinogenesis.
    Lee GH; Ogawa K; Drinkwater NR
    Am J Pathol; 1995 Dec; 147(6):1811-22. PubMed ID: 7495305
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multiple genetic alterations in malignant metastatic insulinomas.
    Pavelić K; Hrasćan R; Kapitanović S; Karapandza N; Vranes Z; Belicza M; Kruslin B; Cabrijan T
    J Pathol; 1995 Dec; 177(4):395-400. PubMed ID: 8568594
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pancreatic beta-cell-specific ablation of the multiple endocrine neoplasia type 1 (MEN1) gene causes full penetrance of insulinoma development in mice.
    Bertolino P; Tong WM; Herrera PL; Casse H; Zhang CX; Wang ZQ
    Cancer Res; 2003 Aug; 63(16):4836-41. PubMed ID: 12941803
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A morphological analysis endocrine tumour genesis in pancreas and anterior pituitary of AVP/SV40 transgenic mice.
    Rindi G; Bishop AE; Murphy D; Solcia E; Hogan B; Polak JM
    Virchows Arch A Pathol Anat Histopathol; 1988; 412(3):255-66. PubMed ID: 2829418
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Driven by the same Ig enhancer and SV40 T promoter ras induced lung adenomatous tumors, myc induced pre-B cell lymphomas and SV40 large T gene a variety of tumors in transgenic mice.
    Suda Y; Aizawa S; Hirai S; Inoue T; Furuta Y; Suzuki M; Hirohashi S; Ikawa Y
    EMBO J; 1987 Dec; 6(13):4055-65. PubMed ID: 2832150
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of c-myc in the transformation of REF52 cells by viral and cellular oncogenes.
    Kohl NE; Ruley HE
    Oncogene; 1987; 2(1):41-8. PubMed ID: 2830582
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phenobarbital causes apoptosis in conditionally immortalized mouse hepatocytes depending on deregulated c-myc expression: characterization of an unexpected effect.
    Osanai M; Ogawa K; Lee GH
    Cancer Res; 1997 Jul; 57(14):2896-903. PubMed ID: 9230198
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of the amino-terminal domain of simian virus 40 early region in inducing tumors in secretin-expressing cells in transgenic mice.
    Ratineau C; Ronco A; Leiter AB
    Gastroenterology; 2000 Nov; 119(5):1305-11. PubMed ID: 11054388
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bax regulates c-Myc-induced mammary tumour apoptosis but not proliferation in MMTV-c-myc transgenic mice.
    Jamerson MH; Johnson MD; Korsmeyer SJ; Furth PA; Dickson RB
    Br J Cancer; 2004 Oct; 91(7):1372-9. PubMed ID: 15354213
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.